Article in Research square, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Lee H SchwammDepartment of Neurology and Comprehensive Stroke Center, Massachusetts General Hospital and Harvard Medical School Boston, MA.ORCID https://orcid.org/0000-0003-0592-9145
Lauren SansingDepartment of Neurology, Yale School of Medicine, New Haven, CT.
Hooman KamelDepartment of Neurology, Weill Cornell Medicine, New York City, NY.
Adam de HavenonDepartment of Neurology, Yale School of Medicine, New Haven, CT.
Ashby C TurnerDepartment of Neurology and Comprehensive Stroke Center, Massachusetts General Hospital and Harvard Medical School Boston, MA.
Richa SharmaDepartment of Neurology, Yale School of Medicine, New Haven, CT.
Funding
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)U01NS106513 · NINDS · YALE UNIVERSITY · PI Hooman Kamel, Kevin Navin Sheth · 2019 to 2026
$20.6M
Discovery and analysis of the C. elegans neuronal gene expression network (CENGEN)R01NS100547 · NINDS · YALE UNIVERSITY · PI MARC HAMMARLUND, Oliver Hobert · 2017 to 2026
$11.2M
Social networks and risk of delayed arrival to the hospital during strokeR01MD016178 · NIMHD · BRIGHAM AND WOMEN'S HOSPITAL · PI Amar Dhand, Kevin Navin Sheth · 2022 to 2026
$3.7M
The Recovery in Stroke Using PAP (RISE UP) StudyR01NR018335 · NINR · YALE UNIVERSITY · PI REDEKER, NANCY S, SHETH, KEVIN NAVIN · 2019 to 2023
$3.4M
New England Regional Coordinating Center for the NINDS Stroke Trials Network (StrokeNet)U24NS107243 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI ANEESH B SINGHAL · 2018 to 2026
$3.3M
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)U24NS107215 · NINDS · YALE UNIVERSITY · PI MARK Jay ALBERTS, Karen L Furie · 2018 to 2026
$3.0M
Deciphering the regulatory code that specifies different cell fates in development using single cell genomicsR01HD100035 · NICHD · YALE UNIVERSITY · PI GIRALDEZ, ANTONIO J, KRISHNASWAMY, SMITA · 2020 to 2024
$2.8M
Dynamic Neuroimmune Profiling in Patients with Acute Intracerebral HemorrhageR01NS097728 · NINDS · YALE UNIVERSITY · PI SANSING, LAUREN H · 2016 to 2020
$2.8M
The Impact of Telestroke on Patterns of Care and Long-Term OutcomesR01NS111952 · NINDS · HARVARD MEDICAL SCHOOL · PI MEHROTRA, ATEEV · 2019 to 2023
$2.4M
Blood Pressure Variability and Ischemic Stroke Outcome (BP-VISO)R01NS130189 · NINDS · YALE UNIVERSITY · PI Adam H. de Havenon · 2023 to 2026
$2.0M
Deciphering Genetic and Epigenetic Regulatory Logic of Germ Layer Differentiation with Manifold LearningR01GM130847 · NIGMS · YALE UNIVERSITY · PI KRISHNASWAMY, SMITA · 2019 to 2023
$2.0M
Y-SPAN: Yale Translational Cerebroprotection Program in SPANU01NS130585 · NINDS · YALE UNIVERSITY · PI SANSING, LAUREN H · 2023 to 2025
Determining the etiology of an acute ischemic stroke (AIS) is fundamental to secondary stroke prevention efforts but can be diagnostically challenging. We trained and validated an automated classification machine intelligence tool,
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.